We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.
Tresiba is a prescription-only, maximum-potency ultra-long-acting basal insulin analogue. It contains Insulin Degludec and is supplied primarily as a multi-dose pre-filled disposable injection pen (FlexTouch) or as cartridges (Penfill).
It is standardly available in two therapeutic strengths: U-100 (100 units/mL) and U-200 (200 units/mL). It is administered via a Subcutaneous (S.C.) injection once daily by adults, adolescents, and children aged 1 year and older to achieve glycemic control in both Type 1 and Type 2 Diabetes Mellitus.
Traditional long-acting insulins provide background coverage for up to 24 hours, but can still cause blood sugar fluctuations. Tresiba features a unique molecular structure engineered to deliver an exceptionally smooth biological profile:
Soluble Multi-Hexamers Depot: Upon subcutaneous injection, the insulin degludec molecules chemically assemble into a long, interconnected chain of soluble multi-hexamers underneath the skin tissue.
Continuous Slow Dissociation: This matrix acts as a highly stable structural depot. Individual insulin monomers slowly and steadily break off from the chain to pass into the bloodstream at a uniform, flat rate.
The Peakless 42-Hour Shield: This continuous leak provides an ultra-stable metabolic action profile that lasts for at least 42 hours. Because it functions completely without a pronounced peak or drop, it minimizes blood sugar volatility and dramatically lowers your biological risk of nighttime low blood sugar crashes (nocturnal hypoglycemia).
Diabetes Mellitus (Type 1 & Type 2): Long-term baseline (basal) insulin coverage to manage fasting plasma glucose levels. In Type 1 Diabetes, it must always be paired with a rapid-acting mealtime insulin (like NovoRapid or Humalog).
Active Hypoglycemia: Strictly contraindicated during any active episode of low blood sugar.
Thiazolidinedione (TZD) Interactions: If paired with oral diabetes pills called TZDs (such as pioglitazone/Actos), monitor closely for signs of heart failure. Combining insulin with TZDs can cause severe fluid retention and heart strain.
Hypokalemia Susceptibility: Insulin drives potassium from the blood into cells, which can drop your blood potassium parameters. Use with extra monitoring if you take high-dose water pills or suffer from kidney issues.
Pregnancy and Breastfeeding: Tresiba can be used during pregnancy and nursing under close medical observation. Dosage parameters standardly decrease during the first trimester and rise during the second and third trimesters.
The Once-Daily Flexibility Rule: Take your prescribed dose once a day, ideally at the identical hour every day. However, because of its 42-hour duration, it offers a unique dosing flexibility window: if a schedule shift is unavoidable, you can adjust your injection time as long as you ensure a minimum of 8 hours has passed between consecutive injections.
The Subcutaneous Site Rule: Inject strictly into the fat layer right under the skin—standardly in the abdomen, thigh, or upper outer arm. Never inject Tresiba into a vein or a muscle, as this causes the depot to dump into your system immediately, triggering a critical blood sugar crash.
Meticulous Site Rotation: Rotate your injection spot within your chosen area with every single dose. Do not inject into skin that is tender, bruised, hard, or scarred, as this stops lipodystrophy (pits or fat lumps forming under the skin).
The Zero-Conversion Dosing Law: The dose counter window on the FlexTouch pen always displays the exact number of units you need to inject, regardless of the pen's strength (U-100 or U-200). Never perform manual calculations or try to convert your dose when shifting between strengths.
1.Verify your insulin label and attach a fresh needle:Pen Preparation.
Wash your hands. Check the pen label to verify it says "Tresiba" and ensure the fluid inside the glass reservoir window is completely clear, colorless, and free of floating particles. Screw on a fresh, sterile disposable needle (such as a NovoFine needle).
2.Perform a brief 2-unit flow check:Priming (Flow Check).
Turn the dose selector dial to exactly 2 units. Hold the pen upright with the needle pointing up and tap the reservoir gently. Press the injection button completely in. A drop of insulin must appear at the needle tip to clear trapped air bubbles and guarantee an accurate dose.
3.Dial your exact unit dose, insert, and hold for 6 seconds:Delivery Mechanics.
Turn the dial until the window displays your exact prescribed dose number. Clean your skin site with alcohol, pinch the skin slightly, and insert the needle straight down at a 90-degree angle. Press and hold the injection button completely down until the dial window snaps back to 0. Keep the needle held deep in the skin for a full 6 seconds before withdrawing to ensure the full dose has left the pen matrix.
4.Remove the used needle immediately and replace the cap:Safe Storage.
Carefully unscrew the hot, used needle and discard it into a puncture-proof sharps bin. Never store the pen with a needle attached, as this causes insulin to leak out or lets air and bacteria seep inside. Pop the pen cap back on.
As your metabolic pathways adjust to the basal insulin profile, you may notice typical clinical updates:
Hypoglycemia (Low Blood Sugar): The most common side effect. Learn to recognize the warning signs: sudden dizziness, sweating, shakiness, confusion, a rapid heart rate, intense hunger, or blurred vision. Always carry a fast-acting sugar source (such as glucose tablets, fruit juice, or honey) to treat sudden drops immediately.
Minor localized injection site updates, including temporary redness, mild swelling, itching, or minor bruising.
Lipodystrophy (changes in skin thickness or texture if you fail to rotate your weekly injection sites properly).
Mild systemic updates, including minor fluid retention (peripheral edema) causing slight swelling in the hands or ankles, along with temporary mild weight gain early on.
What should I do if I accidentally miss a daily Tresiba dose?
If you realize you have missed a dose, inject your regular prescribed dose immediately upon discovery, and then resume your regular once-daily calendar. Always ensure that you maintain a gap of at least 8 hours between your injections. Never inject a double dose or take two separate doses within an 8-hour window to catch up for a forgotten day.
Can I mix Tresiba in the same syringe with other insulins?
No, absolutely not. Tresiba must strictly never be mixed with any other insulin type or solution. Mixing it with other fluids alters its chemical pH, destroying the soluble multi-hexamer formation mechanism and completely neutralizing its ultra-long-acting properties.
How must the FlexTouch pens be stored safely?
Unused Pens: Keep your unopened Tresiba pens stored securely inside the refrigerator between 2°C and 8°C. Never freeze them. If a pen accidentally freezes, discard it immediately.
In-Use Pens: Once you use a pen for the first time, you can keep it at cool room temperature strictly below 30°C or inside the refrigerator for up to 8 weeks (56 days). Keep the pen cap on when not in use to protect the clear insulin matrix from direct sunlight, and keep it completely out of the sight and reach of children.
Advanced, ultra-long-acting basal insulin analogues are highly temperature-sensitive and require strict cold-chain infrastructure to prevent the degradation of the delicate protein structures. To eliminate the high global risks of counterfeit, expired, or improperly stored biologics, Tresiba requires rigid supply chain auditing and continuous cold-chain tracking to and from the manufacturer to the patient. Hospital procurement teams, metabolic health clinics, and individual diabetic patients can securely submit prescriptions and buy genuine, factory-authenticated Tresiba FlexTouch Injections (manufactured by Novo Nordisk, NAFDAC Reg. No. A6-0484) online through Sanlive Pharmacy & Stores for verified payment and rapid, cold-chain validated distribution directly to your home, office, or clinical suite within Lagos, Abuja, Port Harcourt, and nationwide via our trusted specialty clinical logistics networks.
Important Notice: This information is for educational and procurement support purposes only. Tresiba is a maximum-potency, prescription-only basal biologic medication. Your entire therapeutic layout, dosage adjustments, and routine metabolic metrics (including fasting blood glucose tracking and HbA1c monitoring) must be managed under the direct physical direction of a registered Endocrinologist, Diabetologist, or Physician. If a patient experiences severe un-responsive hypoglycemia leading to confusion or a loss of consciousness, experiences signs of an active systemic anaphylactic reaction, or develops deep rapid breathing, administer emergency glucagon or activate immediate emergency medical resuscitation protocols at a hospital straight away.
No reviews yet — be the first!
Log in to write a review.
.jpg)
